intracellular lambda light chain levels (Bethyl)
Bethyl is a verified supplier 
93
Structured Review
Bethyl
intracellular lambda light chain levels
Intracellular Lambda Light Chain Levels, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 52 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intracellular+lambda+light+chain+levels/Human+Lambda+ELISA+Kit/pm41861438-243-18-30
Average 93 stars, based on 52 article reviews
Intracellular Lambda Light Chain Levels, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 52 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intracellular+lambda+light+chain+levels/Human+Lambda+ELISA+Kit/pm41861438-243-18-30
Average 93 stars, based on 52 article reviews
intracellular lambda light chain levels - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Generated:Article Title: Incorporation of an alpha-hydroxy substituent modulates activity of triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors. Article Snippet: Geranylgeranyl diphosphate synthase (GGDPS), the enzyme responsible for producing the isoprenoid substrate used in protein geranylgeranylation reactions, represents a novel therapeutic target in cancer, including malignancies such as multiple myeloma and osteosarcoma.. Our work has focused on the development of a series of isoprenoid triazole bisphosphonate-based GGDPS inhibitors.. Previous work has revealed that our lead GGDPS inhibitors do achieve substantial systemic distribution, in contrast to clinically used nitrogenous bisphosphonates which accumulate primarily in the bone. Western Blot:Article Title: Incorporation of an alpha-hydroxy substituent modulates activity of triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors. Article Snippet: Geranylgeranyl diphosphate synthase (GGDPS), the enzyme responsible for producing the isoprenoid substrate used in protein geranylgeranylation reactions, represents a novel therapeutic target in cancer, including malignancies such as multiple myeloma and osteosarcoma.. Our work has focused on the development of a series of isoprenoid triazole bisphosphonate-based GGDPS inhibitors.. Previous work has revealed that our lead GGDPS inhibitors do achieve substantial systemic distribution, in contrast to clinically used nitrogenous bisphosphonates which accumulate primarily in the bone. Enzyme-linked Immunosorbent Assay:Article Title: Incorporation of an alpha-hydroxy substituent modulates activity of triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors. Article Snippet: Geranylgeranyl diphosphate synthase (GGDPS), the enzyme responsible for producing the isoprenoid substrate used in protein geranylgeranylation reactions, represents a novel therapeutic target in cancer, including malignancies such as multiple myeloma and osteosarcoma.. Our work has focused on the development of a series of isoprenoid triazole bisphosphonate-based GGDPS inhibitors.. Previous work has revealed that our lead GGDPS inhibitors do achieve substantial systemic distribution, in contrast to clinically used nitrogenous bisphosphonates which accumulate primarily in the bone. |